Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y1 Receptor

Qiaoling Jiang, Danping Guo, Brian X. Lee, A. Michiel Van Rhee, Yong-Chul Kim, Robert A. Nicholas, Joel B. Schachter, T. Kendall Harden and Kenneth A. Jacobson
Molecular Pharmacology September 1997, 52 (3) 499-507; DOI: https://doi.org/10.1124/mol.52.3.499
Qiaoling Jiang
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danping Guo
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian X. Lee
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Michiel Van Rhee
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-Chul Kim
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Nicholas
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel B. Schachter
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Kendall Harden
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Jacobson
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 (Q.J., D.G., B.X.L., A.M.v. R., Y.-C.K., K.A.J.), and 2Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (R.A.N., J.R.S., T.K.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 52 (3)
Molecular Pharmacology
Vol. 52, Issue 3
1 Sep 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y1 Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
Citation Tools
Research ArticleArticle

A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y1 Receptor

Qiaoling Jiang, Danping Guo, Brian X. Lee, A. Michiel Van Rhee, Yong-Chul Kim, Robert A. Nicholas, Joel B. Schachter, T. Kendall Harden and Kenneth A. Jacobson
Molecular Pharmacology September 1, 1997, 52 (3) 499-507; DOI: https://doi.org/10.1124/mol.52.3.499

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y1 Receptor

Qiaoling Jiang, Danping Guo, Brian X. Lee, A. Michiel Van Rhee, Yong-Chul Kim, Robert A. Nicholas, Joel B. Schachter, T. Kendall Harden and Kenneth A. Jacobson
Molecular Pharmacology September 1, 1997, 52 (3) 499-507; DOI: https://doi.org/10.1124/mol.52.3.499
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide
  • Operational Models for Receptors with Multiple Agonist Sites
  • BODIPY-cyclopamine Binding to Nluc-SMO
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics